BULKGLP RESEARCH LIBRARY
KLOW: formulation identity and blend documentation
Published
KLOW is a four-component research blend
KLOW is a formulation name for a mixture containing BPC-157, KPV, a TB-500-labeled component and GHK-Cu. The catalog describes a nominal 80 mg total. That total is not an amount for each ingredient and does not establish their proportions. A blend also has no single peptide sequence or molecular weight: each component retains its own chemical identity.
The source description specifies the TB-500-labeled component as Ac-LKKTETQ, an acetylated seven-residue fragment associated with thymosin beta-4. This qualification matters because the TB-500 label is used inconsistently across sources. This page does not substitute full-length thymosin beta-4 or assume that another supplier's TB-500 material is the same fragment.
| Material class | Multi-component peptide / copper-peptide research blend |
|---|---|
| Catalog-listed components | BPC-157; KPV; TB-500 component specified as Ac-LKKTETQ; GHK-Cu |
| Nominal total amount | 80 mg for the catalog-listed unit; not component-specific measured content |
| Component amounts and ratio | Not established by the catalog description; no ratio assigned |
| Single CAS registry number | Not applicable to this multi-component formulation |
| Single molecular formula | Not applicable; the mixture is not one molecular entity |
| Single molecular weight | Not applicable; evaluate each specified component separately |
| Single amino acid sequence | Not applicable; ingredient identities require individual sequence / complex specifications |
| Counterions, hydration and excipients | Require formulation and lot documentation; not inferred from component names |
Defining each ingredient before comparison
BPC-157 identifies a fifteen-residue peptide. KPV is the tripeptide Lys-Pro-Val. The acetylated fragment Ac-LKKTETQ differs in length and terminal chemistry from full-length thymosin beta-4. GHK-Cu introduces another distinction: Gly-His-Lys is the peptide ligand, while the supplied copper complex requires a metal-containing identity specification. Listing these names together does not resolve their salt forms, terminal chemistry or copper stoichiometry.
A complete blend specification therefore identifies every ingredient and the basis of its amount. It should distinguish nominal formulation targets from measurements of a submitted sample. Equal ingredient shares must not be inferred from an 80 mg total, and a component mass cannot be recovered from that total without additional composition data.
Analytical questions for a multi-component sample
A suitable identity assessment needs to distinguish all four intended components in the mixture. Detecting one expected mass does not confirm the other ingredients. Retention behavior, molecular ions, fragmentation and comparison materials may contribute evidence, but the report must identify which component each observation supports. Unresolved or overlapping signals require additional method development before they can be interpreted confidently.
Quantifying a mixture is different from reporting an overall chromatographic percentage. Peak areas can depend on detector response as well as amount, so a large peak cannot simply be assigned the same mass share. Component-specific content measurements need an appropriate quantitative basis, calibration and separation or selectivity. Review how the method treats the copper complex rather than assuming a free-peptide signal measures the entire GHK-Cu ingredient.
Evidence, batch records and laboratory suitability
Published experiments on an individual ingredient do not demonstrate that the complete KLOW blend has the same behavior. They also do not establish an additive or synergistic interaction among the four ingredients. Investigating a mixture requires controls that can separate the mixture response from the responses of its components and from the experimental matrix.
Match the received unit and lot to its actual documentation. Record any measured per-component amounts, the defined formulation, analytical limitations and documented handling requirements. A report for a different blend or a single ingredient cannot certify this formulation. Materials are supplied for laboratory research only; this reference contains no use schedule or preparation protocol.
Frequently asked questions
Does 80 mg mean 20 mg of each component?
No. The nominal total does not establish equal portions. The catalog description does not provide individual amounts, so this reference assigns no component ratio.
Can one CAS number or sequence describe KLOW?
No. Those identifiers belong to defined ingredients. KLOW is a multi-component formulation and needs a composition record rather than an invented single-molecule identifier.
Primary sources and chemical records
- PubChem: BPC-157 parent reference, CID 9941957
- PubChem: Lys-Pro-Val / MSH (11-13), CID 125672
- PubChem: prezatide copper reference, CID 71587328
- USP researchers: reference standards and quality characterization of synthetic peptides (2023)
Prepared by BulkGLP. Editorial review: 2026-11-04.